| ACET |    | Adicet Bio, Inc. - Common Stock | | | -10.6% -10.6% 0 | | + Medicine, Cancer fight
| + My List |
| ADAP | | Adaptimmune Therapeutics plc - American Depositary Shares | | | 8.57% 8.57% 0 | | + Medicine, Cancer fight
Last highlighted: #ADAP SEC report: Adaptimmune Therapeutics PLC Statement of changes in beneficial ownership of securities | + My List |
| AEMD | | Aethlon Medical, Inc. - Common Stock | | | up -8.91% 8.91 | | + Health Devices, Medicine, Cancer fight
| + My List |
| AFMD | | Affimed N.V. - Common Stock | | | -11.24% -11.24% 0 | | + Immunology, Cancer fight, Medicine
| + My List |
| AGEN | | Agenus Inc. - Common Stock | | | 6.58% down 9.21% -2.63 | | + Cancer fight, Immunology, Medicine
Last highlighted: #AGEN SEC report: AGENUS INC Statement of changes in beneficial ownership of securities | + My List |
| AIKI | | AIkido Pharma Inc. - Common Stock | | | 0 | | + Cancer fight, Pharmaceutical , Medicine
Last highlighted: #AIKI SEC report: AIkido Pharma Inc. Current report, item 8.01
SEC Filing Form 8-K filed by AIkido Pharma Inc. -- SEC File Number 211098058 | + My List |
| AKER | | Akers Biosciences Inc. - Common Stock | | | 0.00% 0 | | + Medicine, Pharmaceutical , Immunology, Cancer fight
| + My List |
| ALLO | | Allogene Therapeutics, Inc. - Common Stock | | | 4.34% up -11.24% 15.58 | | + Cancer fight, Gene and cell, Medicine
| + My List |
| ALPN | | Alpine Immune Sciences, Inc. - Common Stock | | | 12.35% 12.35% 0 | | + Medicine, Cancer fight
| + My List |
| ALRN | | Aileron Therapeutics, Inc. - Common Stock | | | 0 | | + Cancer fight, Medicine, Biopharma
| + My List |
| ALXO | | ALX Oncology Holdings Inc. - Common Stock | | | -7.3% -7.3% 0 | | + Medicine, Cancer fight
| + My List |
| ANAB | | AnaptysBio, Inc. - Common Stock | | | 0.09% up -7.22% 7.31 | | + Immunology, Cancer fight, Medicine
| + My List |
| ANCN | | Anchiano Therapeutics Ltd. - American Depositary Shares | | | 0.00% 0 | | + Cancer fight, Biopharma, Medicine, Country: Israel
| + My List |
| ANIX | | Anixa Biosciences, Inc. - Common Stock | | | -11.94% -11.94% 0 | | + Cancer fight, Medicine, Immunology
| + My List |
| ANPC | | AnPac Bio-Medical Science Co., Ltd. - American Depositary Shares | | | 0 | | + Cancer fight
Last highlighted: #ANPC SEC report: AnPac Bio-Medical Science Co., Ltd. [Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
SEC Filing Form 20-F/A filed by AnPac Bio-Medical Science Co., Ltd. -- SEC File Number 211081601 | + My List |
| APOP | | Cellect Biotechnology Ltd. - American Depositary Shares | | | 0.00% 0 | | + Country: Israel, Cancer fight, Medicine
| + My List |
| APRE | | Aprea Therapeutics, Inc. - Common Stock | | | -24.17% -24.17% 0 | | + Medicine, Cancer fight
Last highlighted: Aprea Therapeutics Inc trading halted, news pending
$APRE | + My List |
| ARAV | | Aravive, Inc. - Common Stock | | | 10.34% 10.34% 0 | | + Medicine, Cancer fight
| + My List |
| ATNX | | Athenex, Inc. - Common Stock | | | 0 | | + Cancer fight, Biopharma, Covid (fighting)
Last highlighted: $ATNX 📜 SEC Form 10-Q filed by Athenex, Inc.
https://t.co/1k3SCVGjG9
30 seconds delayed. | + My List |
| AUTL | | Autolus Therapeutics plc - American Depositary Shares | | | 13.33% 13.33% 0 | | + Country: Greate Britain, Gene and cell, Cancer fight, Medicine
Last highlighted: $AUTL Autolus Therapeutics to Report First Quarter 2021 Financial Results and Host Conference Call on May 6
https://t.co/Bswi1mwqgf | + My List |
| AVCO | | Avalon GloboCare Corp. - Common Stock | | | 0 | | + Cancer fight, Medicine, Immunology, Pharmaceutical
Last highlighted: #AVCO SEC report: Avalon GloboCare Corp. Current report, items 1.01 and 9.01
SEC Filing Form 8-K filed by Avalon GloboCare Corp. -- SEC File Number 211089336 | + My List |
| AVEO | | AVEO Pharmaceuticals, Inc. - Common Stock | | | 0.75% down 10% -9.25 | | + Medicine, Disease: Oncology, Cancer fight
Last highlighted: #AVEO SEC report: AVEO PHARMACEUTICALS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by AVEO PHARMACEUTICALS, INC. -- SEC File Number 211148137 | + My List |
| AWH | | Aspira Women's Health Inc. - Common Stock | | | 0 | | + Cancer fight, Women Health, Medicine
| + My List |
| AYLA | | Ayala Pharmaceuticals, Inc. - Common Stock | | | -9.8% -9.8% 0 | | + Medicine, Cancer fight
| + My List |
| BLRX | | BioLineRx Ltd. - American Depositary Shares | | | -1.55% down 16.95% -18.5 | | + Medicine, Cancer fight
| + My List |
| BNGO | | Bionano Genomics, Inc. - Common Stock | | | 6.71% down 14.18% -7.47 | | + Medicine, Cancer fight, Gene and cell
Last highlighted: Bionano Genomics Acquires Diagnostics Services Provider Lineagen, Inc. to Accelerate Clinical Adoption of Saphyr for Digital Cytogenetics https://t.co/Q8ywclbV2i | + My List |
| BNGOW | | Bionano Genomics, Inc. - Warrant | | | 0 | | + Cancer fight, Medicine, Gene and cell
| + My List |
| BNR | | Burning Rock Biotech Limited - American Depositary Shares | | | -67.58% -67.58% 0 | | + Country: China, Cancer fight, Medicine
| + My List |
| BPTH | | Bio-Path Holdings, Inc. - Common Stock | | | 1.77% up -7.96% 9.73 | | + Cancer fight, Medicine
| + My List |
| BYSI | | BeyondSpring, Inc. - Ordinary Shares | | | 6.61% up -7.8% 14.41 | | + Cancer fight, Biopharma, Medicine, Immunology
Last highlighted: Form 6-K (report of foreign issuer [rules 13a-16 and 15d-16]) filed with the SEC $BYSI https://t.co/AH1YS5LVCR | + My List |
| CALA | | Calithera Biosciences, Inc. - Common Stock | | | 0 | | + Medicine, Cancer fight
| + My List |
| CBLI | | Cleveland BioLabs, Inc. - Common Stock | | | 0.00% 0 | | + Cancer fight
| + My List |
| CCXI | | ChemoCentryx, Inc. - Common Stock | | | -0.78% down 7.43% -8.21 | | + Biopharma, Cancer fight, Immunology, Medicine
Last highlighted: #CCXI SEC report: ChemoCentryx, Inc. Current report, items 7.01, 8.01, and 9.01 | + My List |
| CELC | | Celcuity Inc. - Common Stock | | | 3.85% up -7.76% 11.61 | | + Cancer fight, Medicine
Last highlighted: #CELC SEC report: Celcuity Inc. Statement of acquisition of beneficial ownership by individuals
SEC Filing Form SC 13G filed by Celcuity Inc. -- SEC File Number 211081754 | + My List |
| CGIX | | Cancer Genetics, Inc. - Common Stock | | | 0.00% 0 | | + Cancer fight, Medicine
| + My List |
| CKPT | | Checkpoint Therapeutics, Inc. - Common Stock | | | -5.56% down 14.73% -20.29 | | + Cancer fight, Medicine
| + My List |
| CLDX | | Celldex Therapeutics, Inc. - Common Stock | | | -5.14% up -7.75% 2.61 | | + Cancer fight, Immunology, Medicine
Last highlighted: #CLDX SEC report: Celldex Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Celldex Therapeutics, Inc. -- SEC File Number 211148052 | + My List |
| CLLS | | Cellectis S.A. - American Depositary Shares | | | -8.15% -8.15% 0 | | + Biopharma, Medicine, Cancer fight
| + My List |
| CLRB | | Cellectar Biosciences, Inc. - Common Stock | | | 0 | | + Medicine, Biopharma, Cancer fight
Last highlighted: #CLRB SEC report: Cellectar Biosciences, Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Cellectar Biosciences, Inc. -- SEC File Number 211087932 | + My List |
| CLSN | | Celsion Corporation - Common Stock | | | -2.49% up -15.05% 12.56 | | + Cancer fight, Medicine
| + My List |
| CMPI | | Checkmate Pharmaceuticals, Inc. - Common Stock | | | 327.57% up 326.75% 0.81999999999999 | | + Cancer fight, Medicine, Pharmaceutical
Last highlighted: #CMPI SEC report: Checkmate Pharmaceuticals, Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Checkmate Pharmaceuticals, Inc. -- SEC File Number 211142205 | + My List |
| CNST | | Constellation Pharmaceuticals, Inc. - Common Stock | | | 0.00% 0 | | + Cancer fight, Medicine, Pharmaceutical
| + My List |
| CRDF | | Cardiff Oncology, Inc. - Common Stock | | | -2.22% down 10.48% -12.7 | | + Cancer fight, Medicine
Last highlighted: #CRDF SEC report: Cardiff Oncology, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Cardiff Oncology, Inc. -- SEC File Number 211148042 | + My List |
| CRIS | | Curis, Inc. - Common Stock | | | up -10% 10 | | + Cancer fight, Medicine
| + My List |
| CSTL | | Castle Biosciences, Inc. - Common stock | | | 0.61% down 8.09% -7.48 | | + Cancer fight, Medicine
| + My List |
| CTMX | | CytomX Therapeutics, Inc. - Common Stock | | | 0.56% down 7.41% -6.85 | | + Biopharma, Cancer fight, Disease: Oncology
- Bad infrastructure
| + My List |
| CUE | | Cue Biopharma, Inc. - Common Stock | | | -1.98% up -14.15% 12.17 | | + Biopharma, Immunology, Cancer fight
| + My List |
| CYCCP | | Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | | | down 21.19% -21.19 | | + Cancer fight, Medicine, Biopharma
Last highlighted: Filing Alert, FORM 8-K [Press/News Current Report] available. $CYCC $CYCCP #CyclacelPharmaceuticals, Inc. https://t.co/wcEcOgiN2c | + My List |
| DCTH | | Delcath Systems, Inc. - Common Stock | | | 2.04% up -7.08% 9.12 | | + Cancer fight, Medicine, Disease: Liver
Last highlighted: #DCTH SEC report: DELCATH SYSTEMS, INC. Notice of Effectiveness | + My List |
| DMTK | | DermTech, Inc. - Common Stock | | | 1.7% down 11.01% -9.31 | | + Medicine, Cancer fight, Skin
Last highlighted: #DMTK SEC report: DermTech, Inc. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by DermTech, Inc. -- SEC File Number | + My List |
| DTIL | | Precision BioSciences, Inc. - Common Stock | | | -2.2% down 8.79% -10.99 | | + Cancer fight, Gene and cell, Food
| + My List |
| ENOB | | Enochian Biosciences, Inc. - Common Stock | | | -7.32% -7.32% 0 | | + Disease: Infectious, Cancer fight, Immunology, Medicine
| + My List |
| EPIX | | ESSA Pharma Inc. - Common Stock | | | 4.45% down 8.01% -3.56 | | + Pharmaceutical , Country: Canada, Cancer fight
Last highlighted: #EPIX SEC report: ESSA Pharma Inc. [Amend] Statement of acquisition of beneficial ownership by individuals
SEC Filing Form SC 13G/A filed by ESSA Pharma Inc. -- SEC File Number 211182253 | + My List |
| EPZM | | Epizyme, Inc. - Common Stock | | | 0 | | + Cancer fight, Gene and cell
| + My List |
| FATE | | Fate Therapeutics, Inc. - Common Stock | | | 0.57% up -8.83% 9.4 | | + Cancer fight, Immunology, Medicine
| + My List |
| FGEN | | FibroGen, Inc - Common Stock | | | -4.02% down 12.85% -16.87 | | + Medicine, Cancer fight, Respiratory therapies / Pulmanory
| + My List |
| FLDM | | Fluidigm Corporation - Common Stock | | | -7.02% -7.02% 0 | | + Life Sciences, Biology, Cancer fight, Biotechnology, RNA
Last highlighted: #FLDM SEC report: FLUIDIGM CORP Current report, items 1.01, 2.03, and 9.01
SEC Filing Form 8-K filed by FLUIDIGM CORP -- SEC File Number 211148270 | + My List |
| FPRX | | Five Prime Therapeutics, Inc. - Common Stock | | | 0.00% 0 | | + Cancer fight, Medicine
| + My List |
| FUSN | | Fusion Pharmaceuticals Inc. - Common Shares | | | -32.31% -32.31% 0 | | + Pharmaceutical , Country: Canada, Medicine, Radiotherapy, Cancer fight
| + My List |
| GALT | | Galectin Therapeutics Inc. - Common Stock | | | -2.88% up -7.35% 4.47 | | + Cancer fight, Disease: Liver, Skin, Medicine
Last highlighted: #GALT SEC report: GALECTIN THERAPEUTICS INC Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by GALECTIN THERAPEUTICS INC -- SEC File Number 211081679 | + My List |
| GLSI | | Greenwich LifeSciences, Inc. - Common stock | | | -1.69% up -12.57% 10.88 | | + Medicine, Biopharma, Cancer fight, Immunology
| + My List |
| GNCA | | Genocea Biosciences, Inc. - Common Stock | | | 0 | | + Cancer fight, Immunology, Medicine
| + My List |
| GNPX | | Genprex, Inc. - Common Stock | | | -3.21% down 16.03% -19.24 | | + Cancer fight, Disease: Oncology, Medicine
Last highlighted: $GNPX [15s. delayed] filed form 10-Q on August 13, 16:34:15 https://t.co/cEVufMKwcd | + My List |
| GOVX | | GeoVax Labs, Inc. - Common Stock | | | up -22.64% 22.64 | | + Medicine, Cancer fight
| + My List |
| GRTS | | Gritstone Oncology, Inc. - Common Stock | | | -1.73% up -8.08% 6.35 | | + Medicine, Immunology, Cancer fight
| + My List |
| GTH | | Genetron Holdings Limited - American Depositary Shares | | | 4.93% down 10.16% -5.23 | | + Cancer fight, Medicine, Disease: Oncology, Country: China
Last highlighted: $GTH / Genetron Holdings Limited ADS files form 6-K https://t.co/3DehdripqL | + My List |
| HCM | | Hutchison China MediTech Limited - American Depositary Shares | | | -13.24% -13.24% 0 | | + Country: China, Medicine, Disease: Oncology, Cancer fight
Last highlighted: $HCM 📜 SEC Form 6-K filed by Hutchison China MediTech Limited
https://t.co/3MQ4DYnXFz
15s delayed. | + My List |
| HGEN | | Humanigen, Inc. - Common Stock | | | -1.93% up -9.18% 7.25 | | + Biopharma, Immunology, Cancer fight, Medicine
Last highlighted: #HGEN SEC report: HUMANIGEN, INC Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by HUMANIGEN, INC -- SEC File Number 211142187 | + My List |
| HOOK | | HOOKIPA Pharma Inc. - Common Stock | | | 2.63% down 10.49% -7.86 | | + Disease: Infectious, Immunology, Cancer fight, Medicine
| + My List |
| HTBX | | Heat Biologics, Inc. - Common Stock | | | -7.41% -7.41% 0 | | + Medicine, Cancer fight
| + My List |
| ICAD | | icad inc. - Common Stock | | | 3.8% up -9.42% 13.22 | | + Medicine, Devices, Cancer fight
Last highlighted: #ICAD SEC report: ICAD INC Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by ICAD INC -- SEC File Number | + My List |
| ILMN | | Illumina, Inc. - Common Stock | | | -6.04% up -20.6% 14.56 | | + Medicine, Gene and cell, Biology, Cancer fight, Reproductive health
Last highlighted: #ILMN SEC report: ILLUMINA, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by ILLUMINA, INC. -- SEC File Number 211148268 | + My List |
| IMMP | | Immutep Limited - American Depositary Shares | | | -9.47% -9.47% 0 | | + Cancer fight, Medicine
| + My List |
| IMNM | | Immunome, Inc. - Common Stock | | | 2.9% down 12.24% -9.34 | | + Cancer fight, Biotechnology, Medicine, Immunology
| + My List |
| IMTX | | Immatics N.V. - Ordinary Shares | | | 5.51% up -12.79% 18.3 | | + Immunology, Cancer fight, Disease: Oncology, Medicine
| + My List |
| INFI | | Infinity Pharmaceuticals, Inc. - Common Stock | | | 0 | | + Medicine, Cancer fight
Last highlighted: #INFI SEC report: INFINITY PHARMACEUTICALS, INC. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by INFINITY PHARMACEUTICALS, INC. -- SEC File Number | + My List |
| INMB | | INmune Bio Inc. - Common stock | | | -7.19% -7.19% 0 | | + Immunology, Cancer fight, Disease: Oncology, Medicine
| + My List |
| IOVA | | Iovance Biotherapeutics, Inc. - Common Stock | | | 1.15% down 8.46% -7.31 | | + Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based
Last highlighted: #IOVA SEC report: IOVANCE BIOTHERAPEUTICS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by IOVANCE BIOTHERAPEUTICS, INC. -- SEC File Number 211148127 | + My List |
| ITOS | | iTeos Therapeutics, Inc. - Common Stock | | | -8.59% -8.59% 0 | | + Cancer fight, Biopharma, Disease: Oncology, Immunology, Medicine
Last highlighted: $ITOS 📜 iTeos Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement
https://t.co/fsH6i8bthL
15s delayed. | + My List |
| JNCE | | Jounce Therapeutics, Inc. - Common Stock | | | 1.9% up -13.51% 15.41 | | + Immunology, Cancer fight, Medicine
| + My List |
| KPTI | | Karyopharm Therapeutics Inc. - Common Stock | | | up -10.02% 10.02 | | + Cancer fight, Disease: Oncology, Pharmaceutical , Medicine
Last highlighted: #KPTI SEC report: Karyopharm Therapeutics Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Karyopharm Therapeutics Inc. -- SEC File Number | + My List |
| KRBP | | Kiromic BioPharma, Inc. - Common Stock | | | 0 | | + Biopharma, Cancer fight, Immunology, Medicine
Last highlighted: #KRBP SEC report: Kiromic Biopharma, Inc. Statement of acquisition of beneficial ownership by individuals | + My List |
| KTRA | | Kintara Therapeutics, Inc. - Common Stock | | | 0 | | + Cancer fight, Medicine
| + My List |
| KURA | | Kura Oncology, Inc. - Common Stock | | | -0.56% up -11.92% 11.36 | | + Cancer fight, Medicine
Last highlighted: #KURA SEC report: Kura Oncology, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Kura Oncology, Inc. -- SEC File Number 211148278 | + My List |
| MACK | | Merrimack Pharmaceuticals, Inc. - Common Stock | | | -2.24% down 7.72% -9.96 | | + Pharmaceutical , Cancer fight, Medicine
| + My List |
| MBRX | | Moleculin Biotech, Inc. - Common Stock | | | -7.58% -7.58% 0 | | + Biotechnology, Pharmaceutical , Medicine, Cancer fight, Disease: Infectious
Last highlighted: #MBRX SEC report: Moleculin Biotech, Inc. Statement of changes in beneficial ownership of securities | + My List |
| MGNX | | MacroGenics, Inc. - Common Stock | | | 4.49% up -9.89% 14.38 | | + Medicine, Cancer fight
| + My List |
| MGTA | | Magenta Therapeutics, Inc. - Common Stock | | | 33.9% 33.9% 0 | | + Gene and cell, Cancer fight, Blood, Immunology, Medicine
Last highlighted: #MGTA SEC report: Magenta Therapeutics, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Magenta Therapeutics, Inc. -- SEC File Number 211084159 | + My List |
| MNPR | | Monopar Therapeutics Inc. - Common Stock | | | -4.48% down 9.19% -13.67 | | + Cancer fight, Medicine, Biopharma
Last highlighted: #MNPR SEC report: Monopar Therapeutics Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Monopar Therapeutics -- SEC File Number 211138054 | + My List |
| MOR | | MorphoSys AG - American Depositary Shares | | | -9.41% -9.41% 0 | | + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight
| + My List |
| MREO | | Mereo BioPharma Group plc - American Depositary Shares | | | 0 | | + Biopharma, Cancer fight, Country: Greate Britain
Last highlighted: #MREO SEC report: Mereo Biopharma Group plc Registration statement by foreign private issuers
SEC Filing Form F-3 filed by Mereo Biopharma Group plc -- SEC File Number 211148904 | + My List |
| MRKR | | Marker Therapeutics, Inc. - Common Stock | | | 0 | | + Immunology, Medicine, Cancer fight
Last highlighted: #MRKR SEC report: Marker Therapeutics, Inc. Current report, items 7.01 and 9.01 | + My List |
| MRSN | | Mersana Therapeutics, Inc. - Common Stock | | | 3.27% up -12.04% 15.31 | | + Medicine, Cancer fight
Last highlighted: #MRSN SEC report: Mersana Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Mersana Therapeutics, Inc. -- SEC File Number | + My List |
| MRUS | | Merus N.V. - Common Shares | | | -2.31% up -9.87% 7.56 | | + Cancer fight, Medicine, Country: Netherlands
Last highlighted: #MRUS SEC report: Merus N.V. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by Merus N.V. -- SEC File Number 211148220 | + My List |
| NCNA | | NuCana plc - American Depositary Shares | | | 0 | | + Cancer fight, Disease: Oncology, Medicine
| + My List |
| NH | | NantHealth, Inc. - Common Stock | | | -8.41% -8.41% 0 | | + Cancer fight, Medicine
- Bad infrastructure
| + My List |
| NK | | NantKwest, Inc. - Common Stock | | | 0.00% 0 | | + Cancer fight, Medicine, Immunology
- Bad infrastructure
| + My List |
| NRIX | | Nurix Therapeutics, Inc. - Common stock | | | -1.03% down 9.91% -10.94 | | + Biotechnology, Cancer fight, Immunology
Last highlighted: #NRIX SEC report: Nurix Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Nurix Therapeutics, Inc. -- SEC File Number 211088020 | + My List |
| NVCR | | NovoCure Limited - Ordinary Shares | | | -4.2% up -8.24% 4.04 | | + Cancer fight, Medicine
| + My List |
| ODT | | Odonate Therapeutics, Inc. - Common Stock | | | 0.00% 0 | | + Cancer fight, Medicine
Last highlighted: #ODT SEC report: Odonate Therapeutics, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Odonate Therapeutics, Inc. -- SEC File Number 211148890 | + My List |
| ONCR | | Oncorus, Inc. - Common Stock | | | 14.75% down 17.31% -2.56 | | + Cancer fight, Immunology, Biotechnology
Last highlighted: #ONCR SEC report: Oncorus, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Oncorus, Inc. -- SEC File Number 211142316 | + My List |
| ONCS | | OncoSec Medical Incorporated - Common Stock | | | 0 | | + Cancer fight, Disease: Oncology, Medicine, Immunology
Last highlighted: #ONCS SEC report: ONCOSEC MEDICAL Inc Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by ONCOSEC MEDICAL Inc -- SEC File Number | + My List |
| ONCY | | Oncolytics Biotech Inc. - Common Shares | | | 6.67% up -10.08% 16.75 | | + Medicine, Cancer fight, Country: Canada, Immunology
Last highlighted: $ONCY / Oncolytics Biotech files form 6-K https://t.co/G1byP6giz8 | + My List |
| ORIC | | Oric Pharmaceuticals, Inc. - Common Stock | | | -7.43% -7.43% 0 | | + Pharmaceutical , Medicine, Disease: Oncology, Cancer fight
Last highlighted: #ORIC SEC report: Oric Pharmaceuticals, Inc. Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by Oric Pharmaceuticals, Inc. -- SEC File Number 211078899 | + My List |
| PDSB | | PDS Biotechnology Corporation - Common Stock | | | 3.28% down 11.36% -8.08 | | + Biotechnology, Immunology, Cancer fight, Disease: Oncology, Medicine
Last highlighted: RT @EdgarInsider: FORM 8-K [Press/News Current Report] recently SEC filed. $PDSB $EDGE PDS Biotechnology Corp https://t.co/FKxSQ3btJT | + My List |
| PHIO | | Phio Pharmaceuticals Corp. - Common Stock | | | up -9.09% 9.09 | | + Medicine, Cancer fight, Immunology
Last highlighted: #PHIO SEC report: Phio Pharmaceuticals Corp. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Phio Pharmaceuticals Corp. -- SEC File Number | + My List |
| PIRS | | Pieris Pharmaceuticals, Inc. - Common Stock | | | -1.14% down 7.06% -8.2 | | + Biopharma, Respiratory therapies / Pulmanory, Medicine, Immunology, Cancer fight
Last highlighted: #PIRS SEC report: PIERIS PHARMACEUTICALS, INC. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by PIERIS PHARMACEUTICALS, INC. -- SEC File Number 211142334 | + My List |
| PMVP | | PMV Pharmaceuticals, Inc. - Common Stock | | | 0.37% down 8.23% -7.86 | | + Medicine, Cancer fight, Pharmaceutical
Last highlighted: #PMVP SEC report: PMV Pharmaceuticals, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by PMV Pharmaceuticals, Inc. -- SEC File Number | + My List |
| POAI | | Predictive Oncology Inc. - Common Stock | | | 0 | | + Cancer fight, Medicine, Artificial Intelligence
Last highlighted: #POAI SEC report: Predictive Oncology Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Predictive Oncology Inc. -- SEC File Number | + My List |
| PRLD | | Prelude Therapeutics Incorporated - Common Stock | | | up -9.42% 9.42 | | + Cancer fight, Medicine
Last highlighted: #PRLD SEC report: Prelude Therapeutics Inc Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Prelude Therapeutics Inc -- SEC File Number | + My List |
| PROG | | Progenity, Inc. - Common Stock | | | -10% -10% 0 | | + Gene and cell, Medicine, Cancer fight, Women Health
Last highlighted: #PROG SEC report: PROGENITY, INC. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by PROGENITY, INC. -- SEC File Number | + My List |
| PSTV | | PLUS THERAPEUTICS, Inc. - Common Stock | | | 0 | | + Cancer fight, Medicine, Radiotherapy
Last highlighted: #PSTV SEC report: PLUS THERAPEUTICS, INC. [Amend] Quarterly report [Sections 13 or 15(d)] | + My List |
| QTRX | | Quanterix Corporation - Common Stock | | | up -8.08% 8.08 | | + Healthcare, Biology, Disease: Infectious, Disease: Cardiovascular, Cancer fight, Disease: Oncology
Last highlighted: #QTRX SEC report: Quanterix Corp Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Quanterix Corp -- SEC File Number | + My List |
| RAPT | | RAPT Therapeutics, Inc. - Common Stock | | | -3.78% down 15.67% -19.45 | | + Cancer fight, Medicine
Last highlighted: #RAPT SEC report: RAPT Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by RAPT Therapeutics, Inc. -- SEC File Number | + My List |
| REPL | | Replimune Group, Inc. - Common Stock | | | -7.44% -7.44% 0 | | + Cancer fight
Last highlighted: #REPL SEC report: Replimune Group, Inc. [Amend] Statement of changes in beneficial ownership of securities
SEC Filing Form 4/A filed by Replimune Group, Inc. -- SEC File Number | + My List |
| RIGL | | Rigel Pharmaceuticals, Inc. - Common Stock | | | 6.83% down 7.14% -0.31 | | + Medicine, Cancer fight
| + My List |
| RUBY | | Rubius Therapeutics, Inc. - Common Stock | | | -13.51% -13.51% 0 | | + Gene and cell, Cancer fight, Medicine
| + My List |
| RVMD | | Revolution Medicines, Inc. - Common Stock | | | -28.74% -28.74% 0 | | + Cancer fight, Medicine, Biotechnology
| + My List |
| SESN | | Sesen Bio, Inc. - Common Stock | | | 0 | | + Cancer fight, Medicine
Last highlighted: #SESN SEC report: Sesen Bio, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Sesen Bio, Inc. -- SEC File Number 211102791 | + My List |
| SLRX | | Salarius Pharmaceuticals, Inc. - Common Stock | | | 0 | | + Cancer fight, Biotechnology, Medicine, Pharmaceutical
Last highlighted: $SLRX 8-K Salarius Pharmaceuticals (8 Mar, 4:30pm)
📰 Salarius Announces Pricing of $20 Million Underwritten Public Offering of Common Stock
https://t.co/AWdEx2wgvD
#SLRX #8K #SalariusPharmaceuticals #News | + My List |
| SLS | | SELLAS Life Sciences Group, Inc. - Common Stock | | | 12.07% 12.07% 0 | | + Cancer fight, Medicine
Last highlighted: SELLAS Announces Positive Follow-up Data from the Randomized Phase 2 VADIS Trial of Nelipepimut-S (NPS) in Women with Ductal Carcinoma In-Situ of the Breast
https://www.sellaslifesciences.com/investors/news/News-Details/2020/SELLAS-Announces-Positive-Follow-up-Data-from-the-Randomized-Phase-2-VADIS-Trial-of-Nelipepimut-S-NPS-in-Women-with-Ductal-Carcinoma-In-Situ-of-the-Breast/default.aspx | + My List |
| SNSS | | Sunesis Pharmaceuticals, Inc. - Common Stock | | | 0.00% 0 | | + Medicine, Biopharma, Cancer fight
| + My List |
| SONN | | Sonnet BioTherapeutics Holdings, Inc. - Common Stock | | | 0 | | + Cancer fight, Biology, Medicine
| + My List |
| SRNE | | Sorrento Therapeutics, Inc. - Common Stock | | | 6.92% down 7.44% -0.52 | | + Pain fight, Cancer fight, Medicine
| + My List |
| STRO | | Sutro Biopharma, Inc. - Common Stock | | | 4.18% up -8.73% 12.91 | | + Cancer fight, Medicine
| + My List |
| SURF | | Surface Oncology, Inc. - Common Stock | | | 1.46% down 8.33% -6.87 | | + Cancer fight, Immunology, Medicine
Last highlighted: #SURF SEC report: Surface Oncology, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Surface Oncology, Inc. -- SEC File Number 211078938 | + My List |
| SYRS | | Syros Pharmaceuticals, Inc. - common stock | | | up -16.83% 16.83 | | + Gene and cell, Medicine, Cancer fight
| + My List |
| TARA | | Protara Therapeutics, Inc. - Common Stock | | | 4.49% down 7.96% -3.47 | | + Cancer fight, Medicine
| + My List |
| TCON | | TRACON Pharmaceuticals, Inc. - Common Stock | | | -1.54% down 13.53% -15.07 | | + Pharmaceutical , Cancer fight, Medicine, Biopharma, Disease: Oncology
| + My List |
| TCRR | | TCR2 Therapeutics Inc. - Common Stock | | | -2.07% down 8.76% -10.83 | | + Cancer fight, Medicine
| + My List |
| THTX | | Theratechnologies Inc. - Common Shares | | | 4.82% down 7.26% -2.44 | | + Cancer fight, Biopharma, Medicine
| + My List |
| TRIL | | Trillium Therapeutics Inc. - Common Shares | | | 0.00% 0 | | + Country: Canada, Cancer fight, Disease: Oncology, Immunology
Last highlighted: #TRIL SEC report: Trillium Therapeutics Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Trillium Therapeutics Inc. -- SEC File Number | + My List |
| TTOO | | T2 Biosystems, Inc. - Common Stock | | | 0 | | + Medicine, Cancer fight
Last highlighted: #TTOO SEC report: T2 Biosystems, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by T2 Biosystems, Inc. -- SEC File Number | + My List |
| TYME | | Tyme Technologies, Inc. - Common Stock | | | 0 | | + Cancer fight, Medicine
Last highlighted: #TYME SEC report: TYME TECHNOLOGIES, INC. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by TYME TECHNOLOGIES, INC. -- SEC File Number | + My List |
| VBLT | | Vascular Biogenics Ltd. - Ordinary Shares | | | 9.22% 9.22% 0 | | + Country: Israel, Biopharma, Cancer fight, Medicine
| + My List |
| VERU | | Veru Inc. - Common Stock | | | -10.11% -10.11% 0 | | + Cancer fight, Medicine
Last highlighted: Veru, Inc. (VERU) CEO Mitchell Steiner on Q4 2020 Results - Earnings Call Transcript | + My List |
| VRAY | | ViewRay, Inc. - Common Stock | | | -5.14% down 8.55% -13.69 | | + Cancer fight, Radiotherapy, Medicine
Last highlighted: #VRAY SEC report: ViewRay, Inc. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by ViewRay, Inc. -- SEC File Number 211148242 | + My List |
| VSTM | | Verastem, Inc. - Common Stock | | | 9.26% 9.26% 0 | | + Biopharma, Cancer fight, Medicine
Last highlighted: #VSTM SEC report: Verastem, Inc. Automatic shelf registration statement of securities of well-known seasoned issuers
SEC Filing Form S-3ASR filed by Verastem, Inc. -- SEC File Number 211136620 | + My List |
| XBIO | | Xenetic Biosciences, Inc. - Common Stock | | | 0 | | + Biopharma, Cancer fight, Disease: Oncology, Medicine
| + My List |
| XFOR | | X4 Pharmaceuticals, Inc. - Common Stock | | | -8.73% -8.73% 0 | | + Cancer fight, Medicine, Pharmaceutical
Last highlighted: #XFOR SEC report: X4 Pharmaceuticals, Inc Current report, item 2.02
SEC Filing Form 8-K filed by X4 Pharmaceuticals, Inc -- SEC File Number 211138073 | + My List |
| YMAB | | Y-mAbs Therapeutics, Inc. - Common Stock | | | -3.74% down 13.19% -16.93 | | + Biopharma, Cancer fight, Medicine
Last highlighted: #YMAB SEC report: Y-mAbs Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Y-mAbs Therapeutics, Inc. -- SEC File Number 211148421 | + My List |
| ZIOP | | ZIOPHARM Oncology Inc - Common Stock | | | -8.18% -8.18% 0 | | + T cell-based, Cancer fight, Disease: Oncology, Immunology, Medicine
| + My List |
| ZNTL | | Zentalis Pharmaceuticals, Inc. - common stock | | | 4.73% down 18.04% -13.31 | | + Cancer fight, Biology, Pharmaceutical , Medicine
Last highlighted: #ZNTL SEC report: Zentalis Pharmaceuticals, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Zentalis Pharmaceuticals, Inc. -- SEC File Number | + My List |
| BCTX | | BriaCell Therapeutics Corp. - Common Shares | | | 6.3% up -8.37% 14.67 | | + Cancer fight, Immunology, Medicine, Disease: Oncology
Last highlighted: #BCTX SEC report: BriaCell Therapeutics Corp. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by BriaCell Therapeutics Corp. -- SEC File Number 211182540 | + My List |
| BOLT | | Bolt Biotherapeutics, Inc. - Common Stock | | | -9.36% -9.36% 0 | | + Immunology, Cancer fight, Disease: Oncology, Medicine
| + My List |
| ENVB | | Enveric Biosciences, Inc. - Common Stock | | | -10.68% -10.68% 0 | | + Biotechnology, Cancer fight, Medicine, Cannabis, Disease: Oncology
Last highlighted: #ENVB SEC report: Enveric Biosciences, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Enveric Biosciences, Inc. -- SEC File Number 211084155 | + My List |
| EVAX | | Evaxion Biotech A/S - American Depositary Share | | | 6.15% down 7.45% -1.3 | | + Cancer fight, Disease: Oncology, Immunology, Medicine, Biotechnology, Biology
Last highlighted: #EVAX SEC report: Evaxion Biotech A/S Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Evaxion Biotech A/S -- SEC File Number 211078935 | + My List |
| FSTX | | F-star Therapeutics, Inc. - Common Stock | | | -7.23% -7.23% 0 | | + Immunology, Medicine, Cancer fight, Disease: Oncology
Last highlighted: #FSTX SEC report: F-star Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by F-star Therapeutics, Inc. -- SEC File Number | + My List |
| GTBP | | GT Biopharma, Inc. - Common Stock | | | 15.42% 15.42% 0 | | + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight
Last highlighted: #GTBP SEC report: GT Biopharma, Inc. Notification of inability to timely file Form 10-Q or 10-QSB
SEC Filing Form NT 10-Q filed by GT Biopharma, Inc. -- SEC File Number 211181131 | + My List |
| LIXT | | Lixte Biotechnology Holdings, Inc. - Common Stock | | | up -19.83% 19.83 | | + Biotechnology, Cancer fight, Disease: Oncology, Medicine
Last highlighted: #LIXT SEC report: LIXTE BIOTECHNOLOGY HOLDINGS, INC. Current report, item 5.07
SEC Filing Form 8-K filed by LIXTE BIOTECHNOLOGY HOLDINGS, INC. -- SEC File Number 211083663 | + My List |
| OCX | | OncoCyte Corporation - Common Stock | | | -7.83% down -3.48% -4.35 | | + Cancer fight, Diagnosing, Medicine
Last highlighted: #OCX SEC report: OncoCyte Corp Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by OncoCyte Corp -- SEC File Number 211160996 | + My List |
| PPBT | | Purple Biotech Ltd. - American Depositary Shares | | | 7.93% up 6.55% 1.38 | | + Country: Israel, Cancer fight, Disease: Oncology
| + My List |
| PRTG | | Portage Biotech Inc. - Common Stock | | | 8.5% 8.5% 0 | | + Country: Canada, Immunology, Cancer fight, Disease: Oncology
| + My List |
| SBTX | | Silverback Therapeutics, Inc. - Common Stock | | | 7.07% 7.07% 0 | | + Cancer fight, Disease: Oncology, Disease: Infectious, Medicine
| + My List |
| SCPS | | Scopus BioPharma Inc. - Common Stock | | | 0 | | + Immunology, Cancer fight, Medicine, Disease: Oncology, Biopharma
Last highlighted: Alert [Quarterly Report] / Form 10-Q filed with the SEC $SCPS Scopus BioPharma Inc. Scopus BioPharma Inc https://t.co/lmBK4v1IJB | + My List |
| VOR | | Vor Biopharma Inc. - Common Stock | | | -4.3% up -7.25% 2.95 | | + Biopharma, Medicine, Cancer fight, Disease: Oncology
| + My List |
| IKNA | | Ikena Oncology, Inc. - Common Stock | | | -14.29% -14.29% 0 | | + Cancer fight, Disease: Oncology, Medicine
| + My List |
| LVTX | | LAVA Therapeutics N.V. - Ordinary Shares | | | -7.1% -7.1% 0 | | + T cell-based, Cancer fight, Medicine, Disease: Oncology
| + My List |